Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria (Q39129403)

9 September 2017

Elevated tumor necrosis factor alpha and interleukin-6 serum levels as markers for complicated Plasmodium falciparum malaria (English)

1 reference

9 September 2017

Plasmodium falciparum

0 references

0 references

0 references

P Kern

1

1 reference

9 September 2017

C J Hemmer

2

1 reference

9 September 2017

J Van Damme

3

1 reference

9 September 2017

H J Gruss

4

1 reference

9 September 2017

M Dietrich

5

1 reference

9 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

American Journal of Medicine

9 September 2017

1 reference

9 September 2017

87

1 reference

9 September 2017

139-143

1 reference

9 September 2017

2

1 reference

Tumour necrosis factor. Another chapter in the long history of endotoxin

9 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

The presence of cachectin/tumor necrosis factor in human disease states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Multiple actions of interleukin 6 within a cytokine network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Interleukin 6, the third mediator of acute-phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 beta and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

T cell growth and differentiation induced by interleukin-HP1/IL-6, the murine hybridoma/plasmacytoma growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Serum levels of interleukin-6 and acute phase responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Interleukin 6 is involved in interleukin 1-induced activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Interferon-gamma, the activated macrophage, and host defense against microbial challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

The role of cachectin/TNF in endotoxic shock and cachexia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Cachectin--Tumour necrosis factor: a cytokine that mediates injury initiated by invasive parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Raised serum levels of tumour necrosis factor in parasitic infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Tumor necrosis factor and interleukin-1 in the serum of children with severe infectious purpura

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Neopterin as a marker for activated cell-mediated immunity: application in HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Haemostatic alterations in malaria correlate to parasitaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Elevated levels of circulating cachectin/tumor necrosis factor in patients with acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

The interferon compartment of the immune response in human malaria: II. Presence of serum-interferon gamma following the acute attack.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Production of B cell stimulatory factor-2 and interferon gamma in the central nervous system during viral meningitis and encephalitis. Evaluation in a murine model infection and in patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

Concentrations of immunoreactive human tumor necrosis factor alpha produced by human mononuclear cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Possible importance of macrophage-derived mediators in acute malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980688-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(89)80688-6

1 reference

9 September 2017

1 reference